Christopher C. Mcconkey

Coventry, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial.

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial.

Journal: Lancet (London, England)
Published: October 11, 2018

The impact of institutional clinical trial recruitment versus hospital volume on survival outcomes of patients with head and neck cancer: An analysis of the PET-NECK trial outcomes, UKCRN portfolio, and Hospital Episode Statistics (HES) in England.

The impact of institutional clinical trial recruitment versus hospital volume on survival outcomes of patients with head and neck cancer: An analysis of the PET-NECK trial outcomes, UKCRN portfolio, and Hospital Episode Statistics (HES) in England.

Journal: Oral oncology
Published: April 09, 2018

Cost-effectiveness analysis of PET-CT-guided management for locally advanced head and neck cancer.

Cost-effectiveness analysis of PET-CT-guided management for locally advanced head and neck cancer.

Journal: European journal of cancer (Oxford, England : 1990)
Published: June 29, 2017

Hand exercises for patients with rheumatoid arthritis: an extended follow-up of the SARAH randomised controlled trial.

Hand exercises for patients with rheumatoid arthritis: an extended follow-up of the SARAH randomised controlled trial.

Journal: BMJ open
Published: April 14, 2017

PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer.

PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer.

Journal: The New England journal of medicine
Published: March 24, 2016

Strengthening And stretching for Rheumatoid Arthritis of the Hand (SARAH). A randomised controlled trial and economic evaluation.

Strengthening And stretching for Rheumatoid Arthritis of the Hand (SARAH). A randomised controlled trial and economic evaluation.

Journal: Health technology assessment (Winchester, England)
Published: March 10, 2015

Exercises to improve function of the rheumatoid hand (SARAH): a randomised controlled trial.

Exercises to improve function of the rheumatoid hand (SARAH): a randomised controlled trial.

Journal: Lancet (London, England)
Published: October 14, 2014

Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasia.

Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasia.

Journal: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
Published: September 16, 2013

Tetraspanins CD9 and CD151, epidermal growth factor receptor and cyclooxygenase-2 expression predict malignant progression in oral epithelial dysplasia.

Tetraspanins CD9 and CD151, epidermal growth factor receptor and cyclooxygenase-2 expression predict malignant progression in oral epithelial dysplasia.

Journal: British journal of cancer
Published: May 17, 2013

Strengthening and stretching for rheumatoid arthritis of the hand (SARAH): design of a randomised controlled trial of a hand and upper limb exercise intervention--ISRCTN89936343.

Strengthening and stretching for rheumatoid arthritis of the hand (SARAH): design of a randomised controlled trial of a hand and upper limb exercise intervention--ISRCTN89936343.

Journal: BMC musculoskeletal disorders
Published: October 09, 2012

The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial.

The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: August 07, 2012

Revising the radiobiological model of synchronous chemotherapy in head-and-neck cancer: a new analysis examining reduced weighting of accelerated repopulation.

Revising the radiobiological model of synchronous chemotherapy in head-and-neck cancer: a new analysis examining reduced weighting of accelerated repopulation.

Journal: International journal of radiation oncology, biology, physics
Published: June 10, 2012
Showing 1-12 of 13

Last Updated: 09/26/2026